BMY vs TECH · P/E 17, rev $48.19B vs P/E 65, rev $1.22B
Bristol-Myers Squibb Company (BMY) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the BMY and TECH stock pages for the full models.
Not investment advice.